President & Chief Executive Officer, Zosano Pharma (NASDAQ: ZSAN)
Dr. Alataris has served as President and Chief Operating Officer since September 2015 and became Zosano’s Chief Executive Officer in January 2016. Dr. Alataris was the Founder and Chief Executive Officer of Nevro Corp. (NYSE:NVRO), a company that developed an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. Under Dr. Alataris’ leadership, Nevro advanced its product from concept to clinical development to market launch leading to successful international commercialization. Following Nevro, Dr. Alataris served as Head of Digital Healthcare Strategy at mc10inc a wearable sensor company, and as the Executive Chairman of the Board of Directors at IRRAS AB, an emerging company developing devices for fluid management and drug delivery in CNS applications.
Prior to founding Nevro Corp, he was Vice President at Bay City Capital, a healthcare focused venture capital firm based in San Francisco. He holds Master’s degrees in Electrical Engineering and Business and a Ph.D. in Biomedical Engineering with emphasis in Neuroscience from the University of Southern California.